Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01345942 · ClinicalTrials.gov registry record · Phase 1
A Study on the Effect of Food on the Pharmacokinetics of RO5428029 in Healthy Volunteers
A Phase 1 study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01345942 is a Phase 1 study that has completed, run by Hoffmann-La Roche. The registered enrollment target is 12 participants.
The verdict
NCT01345942, a Phase 1 study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
This open label, two period, crossover study will evaluate the safety and the effect of food on the pharmacokinetics of RO5428029 in healthy volunteers. In a crossover design, healthy subjects will be randomized to receive a single oral dose of RO5428029 with or without food, with a washout period of at least 7 days between dosing and a follow-up of 7 to 10 days after last dose. Anticipated time on study will be up to 21 days.
Interventions
- DRUG RO5428029
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-05 |
| Est. Completion | 2011-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01345942
The ClinicalTrials.gov registry entry for NCT01345942 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RO5428029 is the first listed.
NCT01345942 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01345942 about?
NCT01345942 is a clinical study titled "A Study on the Effect of Food on the Pharmacokinetics of RO5428029 in Healthy Volunteers". This open label, two period, crossover study will evaluate the safety and the effect of food on the pharmacokinetics of RO5428029 in healthy volunteers. In a crossover design, healthy subjects will be randomized to receive a single oral dose of RO5428029 with or without food, with a washout period o...
What is the current status of trial NCT01345942?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2011-05. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01345942?
The interventions under investigation include: RO5428029 (DRUG).
Who is sponsoring clinical trial NCT01345942?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.